Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid for Damaged Nipples in Breastfeeding Women
NCT05591651Phase 4Recruiting
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium hyaluronate. Primary endpoint: Nipple Trauma Score at 30 days. Started Jan 2023; status: recruiting.
02
Drugs
sodium hyaluronate
Beyond the preview
Go deeper on NCT05591651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591651.